EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase III)

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy

Marianna Fontana iD, John L Berk, Julian D Gillmore, Ronald M Witteles, Martha Grogan, Brian Drachman, Thibaud Damy, Pablo Garcia-Pavia, Jorg Taubel, Scott D Solomon iD, Farooq H Sheikh, Nobuhiro Tahara iD und 26 weitere

New England Journal of Medicine · 02.01.2025 · 392 (1) · 33-44

DOI: 10.1056/nejmoa2409134 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 02.01.2025. Verfasst von Marianna Fontana und 37 weiteren Autor:innen. Beteiligte Einrichtung: From the National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital (M.F., J.D.G.), and Richmond Pharmacology …. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Cardiomyopathies, Prealbumin, RNA, Small Interfering. Die Arbeit wurde bisher 495-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Alnylam Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Neuropathies, FamilialCardiomyopathiesPrealbuminRNA, Small InterferingAgedFemaleHumansMaleMiddle AgedDouble-Blind MethodInjections, SubcutaneousKaplan-Meier EstimateRNAi TherapeuticsWalk TestQuality of LifeAged, 80 and overTreatment Outcome

Substanzen

PrealbuminRNA, Small InterferingTTR protein, human

Autor:innen und Institutionen

  • From the National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital (M.F., J.D.G.), and Richmond Pharmacology (J.T.), London, and the Institute of Cardiovascular and Medical Scienc…

ORCID-Profile: Marianna Fontana, Scott D Solomon, Nobuhiro Tahara, Mathew S Maurer

Förderung

  • Alnylam Pharmaceuticals

Zitieren

APA

Fontana, M., Berk, J. L., Gillmore, J. D., Witteles, R. M., Grogan, M., Drachman, B., Damy, T., Garcia-Pavia, P., Taubel, J., Solomon, S. D., Sheikh, F. H., Tahara, N., González-Costello, J., Tsujita, K., Morbach, C., Pozsonyi, Z., Petrie, M. C., Delgado, D., Van der Meer, P., …, & HELIOS-B Trial Investigators (2025). Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy. New England Journal of Medicine, 392(1), 33-44. https://doi.org/10.1056/nejmoa2409134

Vancouver

Fontana M, Berk JL, Gillmore JD, Witteles RM, Grogan M, Drachman B, et al. Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy. New England Journal of Medicine. 2025;392(1):33-44. doi:10.1056/nejmoa2409134

BibTeX
@article{Fontana2025,
  author = {Fontana, Marianna and Berk, John L and Gillmore, Julian D and Witteles, Ronald M and Grogan, Martha and Drachman, Brian and Damy, Thibaud and Garcia-Pavia, Pablo and Taubel, Jorg and Solomon, Scott D and Sheikh, Farooq H and Tahara, Nobuhiro and González-Costello, José and Tsujita, Kenichi and Morbach, Caroline and Pozsonyi, Zoltán and Petrie, Mark C and Delgado, Diego and Van der Meer, Peter and Jabbour, Andrew and Bondue, Antoine and Kim, Darae and Azevedo, Olga and Hvitfeldt Poulsen, Steen and Yilmaz, Ali and Jankowska, Ewa A and Algalarrondo, Vincent and Slugg, Andrew and Garg, Pushkal P and Boyle, Katherine L and Yureneva, Elena and Silliman, Nancy and Yang, Lilli and Chen, Jihong and Eraly, Satish A and Vest, John and Maurer, Mathew S and HELIOS-B Trial Investigators, HELIOS-B Trial Investigators},
  title = {Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {392},
  number = {1},
  pages = {33--44},
  doi = {10.1056/nejmoa2409134}
}
Kostenlos starten →